10.26.04: Rodman & Renshaw Techvest 6th Annual Healthcare Conference Issue
3 analysts and top management from 105 firms examine the Healthcare sector in this 353 page conference issue from The Wall Street Transcript.

  1. Small to Mid-Cap Biotechnology Companies: Navdeep S. Jaikaria, Rodman & Renshaw

  2. Oncology & Cardiovascular Companies: Reni Benjamin, Rodman & Renshaw

  3. Small Cap Drug Development Companies: Elemer Piros, Rodman & Renshaw

  4. CEO Interviews (average 2,500 words): Top management from 105 sector firms examine the outlook for their firm and the sector. Firms interviewed include: GlycoGenesys, ACADIA Pharmaceuticals, Acusphere, Adherex Technologies, Æterna Zentaris, Akorn, Aksys, Alchemia Limited, Alizyme Plc., Alnylam Pharmaceuticals, Alteon, Amarin Corporation, Ambit Biosciences Corporation, Anadys Pharmaceuticals, Aradigm Corporation, atugen AG, AVANIR Pharmaceuticals, AVANT Immunotherapeutics, Axonyx, BioCryst Pharmaceuticals, Bioenvision, Biomira Inc., Biopure Corporation, BioSante Pharmaceuticals, Callisto Pharmaceuticals, Cambridge Heart, Cell Therapeutics, Celmed Biosciences, Cepheid, CepTor Corporation, Ceptyr, ChemGenex Pharmaceuticals, ChondroGene Limited, Ciphergen Biosystems, CollaGenex Pharmaceuticals, Compugen Ltd., CorAutus Genetics, Corcept Therapeutics, Corgentech, Cortex Pharmaceuticals, Crucell NV, CuraGen Corporation, Cyberkinetics Neurotechnology Systems, Cyclacel Limited, Cypress Bioscience, Dendreon Corporation, diaDexus, DRAXIS Health, DURECT Corporation, Dyax Corp., Emisphere Technologies, Encysive Pharmaceuticals, EPIX Pharmaceuticals, Epoch Biosciences, Genaissance Pharmaceuticals, Genetronics Biomedical Corporation, Genitope Corporation, Grant Life Sciences, Hana Biosciences, Hemispherx Biopharma, IMCOR Pharmaceutical Co., IMI International Medical Innovations, Immunomedics, InKine Pharmaceutical Company, Insmed Incorporated, Inyx, IRIS International, ISIS Pharmaceuticals, ISTA Pharmaceuticals, LAB International, Lipid Sciences, Lorus Therapeutics, MacroChem Corporation, Manhattan Pharmaceuticals, Medarex, Medicure Inc., MediGene AG, MicroIslet, MorphoSys AG, Nanogen, Neoprobe Corporation, Neurobiological Technologies, Northfield Laboratories, Nutrition 21, Nuvelo, Oragenics, Orphan Medical, Pro-Pharmaceuticals, Regeneration Technologies, Rigel Pharmaceuticals, Rita Medical Systems, Sangamo BioSciences, Senomyx, SIGA Technologies, Sontra Medical Corporation, Tanox, Unigene Laboratories, Vascular Solutions, VasGene Therapeutics, Vernalis Plc., VioQuest Pharmaceuticals, Viventia Biotech, Xenomics, Xenova Group Plc and ZIOPHARM.

    Topics covered: Hedge fund interest  - Pulmonary segment  - HIV treatment  - Product pipeline  - ASCO  - Volatility  - Oncology  - New Drug Applications at FDA  - PBA  - Investor concerns  - Approval strategy  - Alzheimer’s treatment 
    Companies covered: United Therapeutics (UTHR), Encysive (ENCY), Keryx (KERX), GlaxoSmithKline (GSK), Trimeris (TRMS), Genetronics Biomedical (GEB), OSI Pharmaceuticals (OSIP), SuperGen (SUPG), BioCryst Pharmaceuticals (BCRX), Vion Pharmaceuticals (VION), AVANIR Pharmaceuticals (AVN), MGI PHARMA (MOGN), Axonyx (AXYX).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE